Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer

Evotec SE has announced the appointment of Dr. Ashiq H. Khan as Executive Vice President and Chief Commercial Officer. Dr. Khan brings over 15 years of international leadership experience in biotech, contract research organizations (CRO), and AI-driven platform businesses. His track record includes managing diverse teams and securing over $7 billion in collaboration agreements.

In his new role, Dr. Khan will aim to expand Evotec’s global commercial organization. His focus will be on driving growth, enhancing industry partnerships, and deepening commercial capabilities. CEO Dr. Christian Wojczewski emphasized Khan's expertise in robotics and AI as crucial for Evotec’s transformation strategy.

Dr. Khan previously held positions at Iktos, Proteros, and Schrödinger. He expressed his commitment to leveraging Evotec’s platforms and expertise to drive next-generation therapies.